ArticleNature medicine2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Inflammatory and Endothelial Dysfunction Biomarkers Predict Severe COVID-19 in Hospitalized Patients: Development of the CCBR Model.Biomedicines · 2026Article
- Assessment of cardiac dysfunction in COVID-19 patients using layer-specific strain echocardiography in short-axis and long-axis views.BMC cardiovascular disorders · 2025Article
- Role of senescence in the chronic health consequences of COVID-19.Translational research : the journal of laboratory and clinical medicine · 2022Review
- Association of cardiometabolic microRNAs with COVID-19 severity and mortality.Cardiovascular research · 2022Article
- Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection.Frontiers in immunology · 2022Review
- SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants.Biomedicines · 2021Review
- An enlightening role for cytokine storm in coronavirus infection.Clinical immunology (Orlando, Fla.) · 2021Review
Corrections and comments
- Erratum for
Authors and funding
50 authors.
Adam G Laing *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Anna Lorenc *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-1406-7607
Irene Del Molino Del Barrio *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Abhishek Das *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-8798-035X
Matthew Fish *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0001-6462-3889
Leticia Monin *The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-4951-8105
Miguel Muñoz-Ruiz *The Francis Crick Institute, London, UK.
Duncan R McKenzie *The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0961-8846
Thomas S Hayday *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Isaac Francos-Quijorna *Regeneration Group, Wolfson Centre for Age-Related Diseases, IoPPN, King's College London, London, UK.
Shraddha Kamdar *Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Magdalene JosephPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Daniel DaviesPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Richard DavisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Aislinn JenningsPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-6954-5717
Iva ZlatarevaPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Pierre VantouroutPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0001-7287-5517
Yin WuPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0003-4080-3935
Vasiliki SofraPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Florencia CanoThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0695-7551
Maria GrecoThe Francis Crick Institute, London, UK.
Efstathios TheodoridisPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Joshua FreedmanPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
Sarah GeePeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-2997-6563
Julie Nuo En ChanComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Sarah RyanDepartment of Inflammation Biology, King's College London, London, UK.
Eva Bugallo-BlancoComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.ORCID http://orcid.org/0000-0002-4350-0625
Pärt PetersonMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0001-6755-791X
Kai KisandMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-5426-4648
Liis HaljasmägiMolecular Pathology Research Group, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Loubna ChadliCenter for Therapeutic Innovation in Immuno-inflammation, Servier, France.
Philippe MoingeonCenter for Therapeutic Innovation in Immuno-inflammation, Servier, France.ORCID http://orcid.org/0000-0002-2380-9983
Lauren MartinezInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-5830-2496
Blair MerrickCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-6061-6064
Karen BisnauthsingCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Kate BrooksInfectious Diseases Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mohammad A A IbrahimImmunological Medicine, Kings College Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0002-0116-597X
Jeremy MasonThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-2796-5123
Federico Lopez GomezThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.ORCID http://orcid.org/0000-0002-7138-3542
Kola BabalolaThe European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Hinxton, UK.
Sultan Abdul-JawadComprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
John CasonDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Christine MantDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Jeffrey SeowDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Carl GrahamDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Katie J DooresDepartment of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, UK.
Francesca Di RosaInstitute of Molecular Biology and Pathology, National Research Council of Italy (CNR), Rome, Italy.
Jonathan EdgeworthCentre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Manu Shankar-HariPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. manu.shankar-hari@kcl.ac.uk.ORCID http://orcid.org/0000-0002-5338-2538
Adrian C HaydayPeter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.ORCID http://orcid.org/0000-0002-9495-5793
Funding
No grant is acknowledged in the PubMed record.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.